Fig. 1 (abstract O35).
From: Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium
![Fig. 1 (abstract O35).](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41512-018-0036-3/MediaObjects/41512_2018_36_Fig13_HTML.png)
Classification plots showing sensitivity (true positive rate, TPR) and false positive rate (FPR) by threshold for the baseline model only (with 95% pointwise confidence intervals of TPR and FPR for risk thresholds of 20%, 30%, 40% for risk of metastatic remnants after chemotherapy in testicular cancer patients)